Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2016 | Subgrouping rarer cancers and clinical trial design

Bruce Johnson, MD, from Dana-Farber Cancer Institute, Boston, MA, explains the challenges associated with developing clinical trials for patients with rarer solid tumors, including defining subgroups of patients for specific therapeutic approaches and recruiting sufficient numbers of participants. Recorded at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO).

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.